Pierpoint Capital

Pierpoint Capital functions as a growth equity firm, co-founding and investing in healthcare technology companies across the U.S. and Israel. It employs a hands-on investment approach, providing strategic, operational, and financial resources to its portfolio. The firm avoids traditional fund limitations, enabling flexible, long-term capital deployment through founder-aligned structures.

Founded in 2014 by Jarret Fass and Richard Krupp, Pierpoint Capital originated from a shared ambition to identify and cultivate distinctive businesses. Fass, an accomplished MedTech investor-operator, focuses on resolving unmet clinical needs with innovative solutions. Krupp contributes to the firm's commitment to impactful enterprises.

Pierpoint Capital collaborates with businesses, especially those advancing healthcare technology, supplying crucial support for their development. The firm’s enduring vision centers on constructing lasting enterprises and addressing substantial market demands through strategic capital and active collaboration with its network of investors.